Risk stratification of performing MRI in patients with MR Unlabelled CIEDs or MR Conditional CIEDs outside specified conditions
Risk category | Scenario | Clinical risk | Level of evidence |
Lowest | MR Conditional CIEDs* (meeting all conditions) | MR safety tested by device manufacturer.25–27 | A |
MR Conditional CIEDs with additional MR Conditional device implanted (eg, coronary stent) | No clinical evidence of increased risk. | A | |
Lower | Recent implants (<6 weeks) | No clinical evidence of increased risk.49 | C |
Unmet condition due to presence of additional implanted device | No clinical evidence of increased risk. | C | |
Temporary surgical epicardial pacing wires (with no external component) | No clinical evidence of increased risk.66–69 | C | |
Unmet patient position exclusion zone, MR Conditional CIEDs | No clinical evidence of increased risk.78 79 | B | |
Scanning beyond SAR restrictions with MR Conditional CIEDs when required for diagnostic imaging | No clinical evidence signal of increased risk.75 76 | C | |
3 T MRI field strength, MR Conditional CIEDs labelled as MR Conditional at 1.5 T only | No clinical evidence of increased risk.80 81 | C | |
MR Unlabelled pin plug with MR Conditional generator and leads | No clinical evidence of increased risk. | C | |
‘Mismatched’ CIEDs with MR Conditional generators, MR Unlabelled leads | No clinical evidence of increased risk.34 | C | |
Intermediate | Inactive, battery-depleted CIEDs | Potential signal of increased risk from one case.34 | C |
Generators implanted outside the pectoral region | Higher risk. | C | |
MR Unlabelled generators, any lead MR labelling (non-pacing dependent) | Risk of device failure. | B | |
MR Unlabelled generators, any lead MR labelling (pacing dependent) | Higher risk of asystole in the event of device failure. | B | |
Abandoned leads (capped or not) | Lead/Tissue heating in experimental studies, no reported clinical complications.49 57 59 60 63–65 | C | |
Higher | Stable abnormal lead parameter | Higher risk, mitigated by investigating cause and appropriate device programming. | C |
CIED component advisory warning | Higher risk depending on cause. | C | |
Permanent epicardial leads | No clinical evidence of increased risk.49 67 | C | |
Fractured leads | Higher risk. | C | |
Battery at elective replacement interval | Higher risk. | C | |
Temporary systems with externalised generator | No clinical evidence of increased risk.49 71 | C | |
Pre-2000 market release generators | Increased risk of electrical reset.45 | B | |
Avoid | Pacing-dependent patients with ICDs devices where not possible to maintain asynchronous pacing (VOO/DOO) | Unavoidable extremely high risk—do not scan. | C |
Scanning any active CIED without reprogramming prior to scan to minimise risk | Risk highly possible—do not scan. | C |
Risk is represented as categories, but within each category the scenarios should be considered as a scale from low to progressively higher risk (top to bottom of the table - shaded from green to red respectively, with black shaded categories representing scenarios where MRI should be avoided). Overall risk is a combined consideration of the likelihood of an event and the clinical outcome if that event occurred. Scenarios considered higher risk either have a paucity of trial data describing clinical safety end points, or are based on expert consensus despite small series reporting safe MRI scanning. Level of evidence A=data derived from multiple randomised controlled trials, or meta-analyses; level of evidence B=data derived from a single randomised clinical trial or large non-randomised study; level of evidence C=consensus of expert opinion based on clinical experience or case series.
*Includes both permanent pacemakers. ICDs and implantable cardiac monitors.
CIED, cardiac implantable electronic device; ICD, implantable cardioverter-defibrillator; NA, not applicable; SAR, specific absorption rate.